Literature DB >> 16467666

Imaging the retina by en face optical coherence tomography.

Mirjam E J van Velthoven1, Frank D Verbraak, Lawrence A Yannuzzi, Richard B Rosen, Adrian G H Podoleanu, Marc D de Smet.   

Abstract

PURPOSE: To present the possibilities of a new system that combines optical coherence tomography (OCT) and confocal ophthalmoscopy, producing en face OCT images in patients with retinal diseases.
METHODS: A prototype OCT Ophthalmoscope (OTI, Toronto, Canada) was used to scan patients with retinal conditions. The system uses a super luminescent diode (lambda = 820 nm; Deltalambda = 20 nm) and currently scans at a rate of 2 frames per second. In each frame, the OCT Ophthalmoscope simultaneously produces a transversal OCT scan and a confocal image in the X/Y plane. Both images correspond pixel to pixel.
RESULTS: Between January 2002 and August 2003, >800 patients with various retinal diseases were scanned with the OCT Ophthalmoscope. Illustrative cases with regularly seen macular diseases are presented, such as macular hole and central serous retinopathy.
CONCLUSION: Current difficulties as well as future possibilities of this new en face OCT ophthalmoscope are discussed. By presenting normal and pathologic transversal OCT images made by a prototype OCT Ophthalmoscope, we show that it can provide information not available using conventional OCT imaging.

Entities:  

Mesh:

Year:  2006        PMID: 16467666     DOI: 10.1097/00006982-200602000-00001

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  15 in total

1.  Multimodal imaging in macular diagnostics: combined OCT-SLO improves therapeutical monitoring.

Authors:  Christian Karl Brinkmann; Sebastian Wolf; Ute Ellen Kathrin Wolf-Schnurrbusch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-03       Impact factor: 3.117

Review 2.  Optical coherence tomography imaging in uveitis.

Authors:  Sumru Onal; Ilknur Tugal-Tutkun; Piergiorgio Neri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-07-09       Impact factor: 2.031

3.  [Three-dimensional imaging in central serous chorioretinopathy].

Authors:  G Stock; C Ahlers; R Sayegh; M Ritter; S Kolar; I Golbaz; U Schmidt-Erfurth
Journal:  Ophthalmologe       Date:  2008-12       Impact factor: 1.059

4.  Optical Coherence Tomography for Ophthalmology Imaging.

Authors:  Jia Qin; Lin An
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Advances in retinal ganglion cell imaging.

Authors:  S I Balendra; E M Normando; P A Bloom; M F Cordeiro
Journal:  Eye (Lond)       Date:  2015-08-21       Impact factor: 3.775

6.  Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT.

Authors:  Li Guo; Eduardo M Normando; Shereen Nizari; David Lara; M Francesca Cordeiro
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-04       Impact factor: 4.799

7.  En face OCT in Stargardt disease.

Authors:  Andrea Sodi; Dario Pasquale Mucciolo; Francesca Cipollini; Vittoria Murro; Orsola Caporossi; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-07       Impact factor: 3.117

8.  Using Retinal Imaging to Study Dementia.

Authors:  Victor T T Chan; Tiffany H K Tso; Fangyao Tang; Clement Tham; Vincent Mok; Christopher Chen; Tien Y Wong; Carol Y Cheung
Journal:  J Vis Exp       Date:  2017-11-06       Impact factor: 1.355

9.  Ultrahigh-speed optical coherence tomography for three-dimensional and en face imaging of the retina and optic nerve head.

Authors:  Vivek J Srinivasan; Desmond C Adler; Yueli Chen; Iwona Gorczynska; Robert Huber; Jay S Duker; Joel S Schuman; James G Fujimoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-24       Impact factor: 4.799

Review 10.  Optical molecular imaging for systems biology: from molecule to organism.

Authors:  Wei Du; Ying Wang; Qingming Luo; Bi-Feng Liu
Journal:  Anal Bioanal Chem       Date:  2006-07-19       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.